User profiles for Susan Hopkins

Susan Hopkins

- Verified email at nhs.net - Cited by 35064

Susan Hopkins

- Verified email at usq.edu.au - Cited by 718

[HTML][HTML] Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015 …

…, S Larsson, JS Reilly, A Johnson, S Hopkins - The Lancet infectious …, 2019 - thelancet.com
Background Infections due to antibiotic-resistant bacteria are threatening modern health
care. However, estimating their incidence, complications, and attributable mortality is …

Transmission of SARS-CoV-2 Lineage B. 1.1. 7 in England: Insights from linking epidemiological and genetic data

…, S Flaxman, O Ratmann, S Bhatt, S Hopkins… - MedRxiv, 2021 - medrxiv.org
The SARS-CoV-2 lineage B.1.1.7, now designated Variant of Concern 202012/01 (VOC) by
Public Health England, originated in the UK in late Summer to early Autumn 2020. We …

[HTML][HTML] Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care …

…, P Kinross, ML Moro, B Jans, S Hopkins… - …, 2018 - eurosurveillance.org
Point prevalence surveys of healthcare-associated infections (HAI) and antimicrobial use in
the European Union and European Economic Area (EU/EEA) from 2016 to 2017 included …

[BOOK][B] Girl heroes: The new force in popular culture

S Hopkins - 2002 - research.usq.edu.au
Examination of women in contemporary popular culture. Looks at female celebrities such as
warrior Xena, the Spice Girls, the Powerpuff Girls and supernatural Buffy. Argues that girls …

[HTML][HTML] Clinical features and management of human monkeypox: a retrospective observational study in the UK

…, O Carpenter, I Cropley, K Frost, S Hopkins… - The Lancet Infectious …, 2022 - thelancet.com
Background Cases of human monkeypox are rarely seen outside of west and central Africa.
There are few data regarding viral kinetics or the duration of viral shedding and no licensed …

[HTML][HTML] Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

…, S Haller, A Haselbeck, SI Hay, M Holm, S Hopkins… - The lancet, 2022 - thelancet.com
Background Antimicrobial resistance (AMR) poses a major threat to human health around
the world. Previous publications have estimated the effect of AMR on incidence, deaths, …

[HTML][HTML] Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant

…, M Zambon, KE Brown, S Hopkins… - … England Journal of …, 2021 - Mass Medical Soc
Background The B.1.617.2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has …

[HTML][HTML] Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant

…, M Zambon, KE Brown, S Hopkins… - The New England …, 2021 - ncbi.nlm.nih.gov
Background The B. 1.617. 2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has …

[HTML][HTML] Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England

…, S Flaxman, O Ratmann, S Bhatt, S Hopkins… - Nature, 2021 - nature.com
The SARS-CoV-2 lineage B.1.1.7, designated variant of concern (VOC) 202012/01 by Public
Health England 1 , was first identified in the UK in late summer to early autumn 2020 2 . …

[HTML][HTML] Duration of protection against mild and severe disease by Covid-19 vaccines

…, M Zambon, K Brown, S Hopkins… - … England Journal of …, 2022 - Mass Medical Soc
Background Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
the virus that causes coronavirus disease 2019 (Covid-19), have been used since …